home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Meetings and Conferences  
 

The 2014 Regenerative Medicine Event: Stem Cell Reprogramming

 
  March 06, 2014  
     
 


EuroSciCon, Cineworld: The O2 Peninsula Square London London SE10 0DX United Kingdom
Monday 2nd June 2014


This event will highlight and discuss recent advances in strategies for controlling stem cell fate and reprogramming. Progress towards therapeutic applications, and new insights into the molecular basis of pluripotency, differentiation, and transdifferentiation will be discussed in an informal setting with plenty of opportunity for networking. This event has CPD accreditation. This event is part ofThe 2014 Tissue Engineering Congress. 

Who Should Attend
Biotech and Pharma Industry:
 CEOs, Chief Scientists, Group Heads, Senior and Junior Scientists, Research Managers
Academic and Research Institutes: 
Group and Lab Heads, Postdoctoral Scientists and Research Students

Meeting Chair:
 
Dr Christopher Ward, Senior Lecturer in Stem Cell Biology, The University ofManchester, UK

The deadline for abstract submissions for oral presentation is March 10th 2014.Abstracts for poster presentation only can be submitted up to two weeks before the event. You can download the instructions for authors at:www.euroscicon.com/AbstractsForOralAndPosterPresentation.pdf 






Keywords: 
 iPSC, hepatocyte, liver, CYP p450, translation, supply chain, delivery, GMP, manufacturing,drug, pluripotent stem cell, hepatocyte, pancreas, liver; beta-cell, Stable Karyoytpe, High-throughput efficiency, Embryonic Stem cells, Induced pluripotency, Nanog, neural stem cell, glioblastoma, DNA methylation, reprogramming, iPS cells, reprogramming, Pluripotentcy, STEMCCA, ESGRO 2i, Pluripotency; reprogramming; chromatin signatures; DNA replication timing; histone acetyltransferase p30, hESC, Drug Metabolism, Hepatocyte, Liver, reprogramming, characterisation, Parkinsons, culture, Chemical Reprogramming, Amniotic Fluid Stem Cells, Induced Pluripotent Stem Cells, Pluripotency Regenerative Medicine, cardiomyocytes, heart disease, human pluripotent stem cells, human neural stem cells, Wnt signalling
 
 
Organized by: Euroscicon
Invited Speakers: Talks include

Progressing human pluripotent stem cell technologies for drug discovery and regenerative medicine by genome engineering
Dr Peter Sartipy,
 Cellectis AB, Göteborg, Sweden

Chemical Reprogramming of Human Amniotic FLuid Stem Cells to Pluripotency
Dr Pascale V Guillot, Senior Lecturer, University College London, UK

Cell Sex Matters. It Could Affect Findings    
Dr Elizabeth Pollitzer
, Portia, London, UK

Disease modelling in a dish: use of cardiovascular derivatives of human pluripotent stem cells
Dr Gabor Foldes,
 Imperial College London, UK

Regulation of human neural stem cell differentiation by noncanonical Wnt signaling
Dr Robert Kypta
, Group Leader, Center for Cooperative Research in Biosciences (CIC bioGUNE) and Imperial College London, UK

Heterogeneity in pluripotent stem cell populations Dr Kirsten Mcewen, MRC Clinical Sciences Centre, UK

Additional confirmed speakers
Dr Christopher Ward
, Senior Lecturer in Stem Cell Biology, The University of Manchester, UK
Speaker to be confirmed, MTS Cryostores, UK
 
Deadline for Abstracts: The deadline for abstract submissions for oral presentation is March 10th 2014.
 
Registration: Registration Website:www.regonline.co.uk/Regen2014
E-mail: enquiries@euroscicon.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.